Benzinga | Nov 10, 2021 05:42PM EST

HTG Molecular Diagnostics Q3 EPS $(0.60) Beats $(0.66) Estimate, Sales $2.50M Miss $2.65M Estimate

HTG Molecular Diagnostics (NASDAQ:HTGM) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.66) by 9.09 percent. This is a 42.86 percent increase over losses of $(1.05) per share from the same period last year. The company reported quarterly sales of $2.50 million which missed the analyst consensus estimate of $2.65 million by 5.66 percent. This is a 40.69 percent increase over sales of $1.78 million the same period last year.